Association Bulletins provide a mechanism for publication of documents that have been approved by the Board of Directors for distribution to individual and institutional members, such as:
#21-02 - Considerations for Implementation of FDA Guidance on Bacterial Risk Controls for Platelets - 06/02/21
#21-01 - Association Bulletin Listings - 02/16/21
Listing of AABB Association Bulletins
Current as of February 16, 2021
| 05/05/20 | #20-04 | The Impact on Blood Safety of Effective Antiretroviral Medications for HIV Prevention and Treatment |
| 04/08/20 | #20-03 | Emergent Standards to the 31st and 32nd editions of Standards for Blood Banks and Transfusion Services |
| 03/19/20 | #20-02 | Recommendations for Providing a Safe Environment for Blood Donation During the COVID-19 Epidemic |
| 06/26/19 | #19-02 | Recommendations on the Use of Group O Red Blood Cells |
| 03/16/17 | #17-02 | Updated Strategies to Limit or Prevent Iron Deficiency in Blood Donors |
| 09/28/16 | #16-07 | Updated Recommendations for Zika, Dengue, and Chikungunya Viruses |
| 01/15/16 | #16-02 | Mitigating the Anti-CD38 Interference with Serologic Testing |
| 12/28/15 | #15-02 | Transfusion-Associated Circulatory Overload (TACO) |
| 07/18/14 | #14-05 | Babesiosis |
| 07/18/14 | #14-04 | Clinical Recognition and Investigation of Suspected Bacterial Contamination of Platelets |
| 01/29/14 | #14-02 | TRALI Risk Mitigation for Plasma and Whole Blood for Allogeneic Transfusion |
| 07/25/13 | #13-03 | Updated Criteria for Donor Deferral and Blood Component Retrieval in Known or Suspected Common Source Outbreaks of Hepatitis A Virus Infection |
| 06/27/13 | #13-02 | West Nile Virus Nucleic Acid Testing – Revised Recommendations |
| 10/04/12 | #12-04 | Recommendations to Address Residual Risk of Bacterial Contamination of Platelets |
| 09/21/12 | #12-02 | TRALI Risk Mitigation Update |
| 11/22/10 | #10-06 | Information Concerning Platelet Additive Solutions |
| 08/28/08 | #08-04 | Strategies to Reduce Adverse Reactions and Injuries in Younger Donors |
| 08/30/06 | #06-05 | Monitoring and Preventing the Occurrence of Deviations and Near-Miss Events in Pretransfusion Testing: Mislabeling/Wrong Blood in Tube |
| 01/24/05 | #05-02 | Guidance on Management of Blood and Platelet Donors with Positive or Abnormal Results on Bacterial Contamination Tests (Supplements #04-07) |
| 10/14/04 | #04-07 | Actions Following an Initial Positive Test for Possible Bacterial Contamination of a Platelet Unit |
| 08/31/04 | #04-06 | Reporting Donor Fatalities |